<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab2">
 <label>Table 2</label>
 <caption>
  <p>Antimicrobial resistance patterns, biofilm forming ability and virulence genes expression levels in 
   <italic>S. agalactiae</italic> isolated from clinical bovine mastitis
  </p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th rowspan="2">Isolate No</th>
    <th rowspan="2">Antimicrobial resistance pattern</th>
    <th colspan="2">Biofilm formation</th>
    <th colspan="6">Virulence genes relative expression
     <sup>b</sup>
    </th>
    <th rowspan="2">Accession No.</th>
   </tr>
   <tr>
    <th>OD570
     <sup>a</sup>
    </th>
    <th>Degree</th>
    <th>
     <italic>hyl</italic>
    </th>
    <th>
     <italic>cylE</italic>
    </th>
    <th>
     <italic>sip</italic>
    </th>
    <th>
     <italic>scpB</italic>
    </th>
    <th>
     <italic>rip</italic>
    </th>
    <th>
     <italic>lmb</italic>
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>1</td>
    <td>P, AX, CX, CRO, CL, FEP, S, DA, TE, E, CFP</td>
    <td>0.498</td>
    <td>Weak</td>
    <td>1.16</td>
    <td>1.09</td>
    <td>–</td>
    <td>1.20</td>
    <td>–</td>
    <td>1.50</td>
    <td>MW133069</td>
   </tr>
   <tr>
    <td>2</td>
    <td>P, AX, CX, CRO, CL, FEP, S, DA, TE, E, AMC</td>
    <td>0.492</td>
    <td>Weak</td>
    <td>1.15</td>
    <td>1.12</td>
    <td>–</td>
    <td>1.21</td>
    <td>–</td>
    <td>1.53</td>
    <td>MW133070</td>
   </tr>
   <tr>
    <td>3</td>
    <td>P, AX, CX, CRO, CL, FEP, S, DA, TE, E, AMC</td>
    <td>1.121</td>
    <td>Strong</td>
    <td>1.10</td>
    <td>1.04</td>
    <td>–</td>
    <td>1.14</td>
    <td>–</td>
    <td>1.42</td>
    <td>MW133071</td>
   </tr>
   <tr>
    <td>4</td>
    <td>P, AX, CX, CRO, CL, FEP, S, DA, TE, E, CFP, SXT, AMC</td>
    <td>0.514</td>
    <td>Weak</td>
    <td>1.14</td>
    <td>1.07</td>
    <td>–</td>
    <td>1.16</td>
    <td>–</td>
    <td>1.43</td>
    <td>MW133072</td>
   </tr>
   <tr>
    <td>5</td>
    <td>P, AX, CX, CRO, CL, FEP, S, DA, TE, E, CFP, SXT</td>
    <td>0.508</td>
    <td>Weak</td>
    <td>1.13</td>
    <td>1.04</td>
    <td>–</td>
    <td>1.15</td>
    <td>–</td>
    <td>1.45</td>
    <td>MW133073</td>
   </tr>
   <tr>
    <td>6</td>
    <td>P, AX, CX, CRO, CL, FEP, S, DA, TE, E, AMC</td>
    <td>0.484</td>
    <td>Weak</td>
    <td>1.16</td>
    <td>0.97</td>
    <td>–</td>
    <td>1.15</td>
    <td>–</td>
    <td>1.46</td>
    <td>MW133074</td>
   </tr>
   <tr>
    <td>7</td>
    <td>P, AX, CX, CRO, CL, FEP, S, DA, TE, E, AMC</td>
    <td>0.812</td>
    <td>Moderate</td>
    <td>1.13</td>
    <td>1.05</td>
    <td>–</td>
    <td>1.23</td>
    <td>–</td>
    <td>1.47</td>
    <td>MW133075</td>
   </tr>
   <tr>
    <td>8</td>
    <td>P, AX, CX, CRO, CL, FEP, S, DA, TE, E, CFP</td>
    <td>0.494</td>
    <td>Weak</td>
    <td>1.37</td>
    <td>1.05</td>
    <td>–</td>
    <td>1.44</td>
    <td>–</td>
    <td>1.81</td>
    <td>MW133076</td>
   </tr>
   <tr>
    <td>9</td>
    <td>P, AX, CX, CRO, CL, FEP, S, DA, TE, E, AMC</td>
    <td>0.492</td>
    <td>Weak</td>
    <td>1.14</td>
    <td>1.13</td>
    <td>–</td>
    <td>1.22</td>
    <td>–</td>
    <td>1.53</td>
    <td>MW133077</td>
   </tr>
   <tr>
    <td>10</td>
    <td>P, AX, CX, CRO, CL, FEP, S, DA, TE, E, AMC</td>
    <td>1.118</td>
    <td>Strong</td>
    <td>1.11</td>
    <td>1.04</td>
    <td>–</td>
    <td>1.04</td>
    <td>–</td>
    <td>1.43</td>
    <td>MW133078</td>
   </tr>
   <tr>
    <td>11</td>
    <td>P, AX, CX, CRO, CL, FEP, S, DA, TE, E, CFP, SXT, AMC</td>
    <td>0.434</td>
    <td>Weak</td>
    <td>1.14</td>
    <td>1.07</td>
    <td>–</td>
    <td>1.14</td>
    <td>–</td>
    <td>1.43</td>
    <td>MW133079</td>
   </tr>
   <tr>
    <td>12</td>
    <td>P, AX, CX, CRO, CL, FEP, S, DA, TE, E, CFP, SXT</td>
    <td>0.528</td>
    <td>Weak</td>
    <td>1.13</td>
    <td>1.04</td>
    <td>–</td>
    <td>1.16</td>
    <td>–</td>
    <td>1.46</td>
    <td>MW133080</td>
   </tr>
   <tr>
    <td>13</td>
    <td>P, AX, CX, CRO, CL, FEP, S, DA, TE, E</td>
    <td>0.470</td>
    <td>Weak</td>
    <td>1.14</td>
    <td>1.03</td>
    <td>–</td>
    <td>1.06</td>
    <td>–</td>
    <td>1.45</td>
    <td>MW133081</td>
   </tr>
   <tr>
    <td>14</td>
    <td>P, AX, CX, CRO, CL, FEP, S, DA, TE, E</td>
    <td>0.820</td>
    <td>Moderate</td>
    <td>1.14</td>
    <td>1.06</td>
    <td>–</td>
    <td>1.15</td>
    <td>–</td>
    <td>1.48</td>
    <td>MW133082</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>
   <italic>P</italic> penicillin G, 
   <italic>AX</italic> amoxicillin, 
   <italic>CX</italic> cloxacillin, 
   <italic>CRO</italic> ceftriaxone, 
   <italic>CL</italic> cephalexin, 
   <italic>FEP</italic> cefepime, 
   <italic>S</italic> streptomycin, 
   <italic>DA</italic> clindamycin, 
   <italic>TE</italic> tetracycline, 
   <italic>E</italic> erythromycin, 
   <italic>CFP</italic> cefoperazone, 
   <italic>AMC</italic> amoxicillin-clavulanic acid, 
   <italic>SXT</italic> trimethoprim-sulfamethoxazole
  </p>
  <p>
   <sup>a</sup> The optical density (OD) was measured at 570 nm using the ELISA reader (stat fax 2100, USA)
  </p>
  <p>
   <sup>b</sup> The expression level of each virulence gene was calculated as the ratio of intensity of the target gene to the internal control gene (
   <italic>gyrA</italic>)
  </p>
 </table-wrap-foot>
</table-wrap>
